Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Hawkins

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Diagnostics (Basel, Switzerland)|June 24, 2022
Acute and Chronic Cardiopulmonary Effects of High Dose Interleukin-2 Therapy: An Observational Magnetic Resonance Imaging StudyJakub Lagan, Josephine H Naish, Christien Fortune, et al.
Research Square|October 3, 2025
Memory deficits in hypertensive ApoE4 mice reversed by P2Y12 inhibition via different mechanisms in males and perimenopausal femalesLianne Trigiani, Nicole Chernavsky, Rachel Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2014
Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES StudyBernard Escudier, Camillo Porta, Petri Bono, et al.
Viruses|October 26, 2024
Utility of ISARIC 4C Mortality Score, Vaccination History, and Anti-S Antibody Titre in Predicting Risk of Severe COVID-19Lin Pin Koh, Travis Ren Teen Chia, Samuel Sherng Young Wang, et al.
Cancer|January 29, 2013
An eHealth system supporting palliative care for patients with non-small cell lung cancer: a randomized trialDavid H Gustafson, Lori L DuBenske, Kang Namkoong, et al.
European Journal of Cancer (Oxford, England : 1990)|August 2, 2011
An international expanded-access programme of everolimus: addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapyViktor Grünwald, Pierre I Karakiewicz, Sevil E Bavbek, et al.
Translational Behavioral Medicine|June 29, 2011
Optimizing eHealth breast cancer interventions: which types of eHealth services are effective?Timothy B Baker, Robert Hawkins, Suzanne Pingree, et al.
European Urology|July 14, 2020
Atezolizumab plus Bevacizumab Versus Sunitinib for Patients with Untreated Metastatic Renal Cell Carcinoma and Sarcomatoid Features: A Prespecified Subgroup Analysis of the IMmotion151 Clinical TrialBrian I Rini, Robert J Motzer, Thomas Powles, et al.
Annals of Surgery|May 15, 2019
Adenosine 2A Receptor Activation Attenuates Ischemia Reperfusion Injury During Extracorporeal Cardiopulmonary ResuscitationJames H Mehaffey, Dustin Money, Eric J Charles, et al.
European Urology Focus|February 11, 2019
Radiological Response Heterogeneity Is of Prognostic Significance in Metastatic Renal Cell Carcinoma Treated with Vascular Endothelial Growth Factor-targeted TherapyPeter E Hall, Scott T C Shepherd, Janet Brown, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Diagnostics (Basel, Switzerland)|June 24, 2022
Acute and Chronic Cardiopulmonary Effects of High Dose Interleukin-2 Therapy: An Observational Magnetic Resonance Imaging StudyJakub Lagan, Josephine H Naish, Christien Fortune, et al.
Research Square|October 3, 2025
Memory deficits in hypertensive ApoE4 mice reversed by P2Y12 inhibition via different mechanisms in males and perimenopausal femalesLianne Trigiani, Nicole Chernavsky, Rachel Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2014
Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES StudyBernard Escudier, Camillo Porta, Petri Bono, et al.
Viruses|October 26, 2024
Utility of ISARIC 4C Mortality Score, Vaccination History, and Anti-S Antibody Titre in Predicting Risk of Severe COVID-19Lin Pin Koh, Travis Ren Teen Chia, Samuel Sherng Young Wang, et al.
Cancer|January 29, 2013
An eHealth system supporting palliative care for patients with non-small cell lung cancer: a randomized trialDavid H Gustafson, Lori L DuBenske, Kang Namkoong, et al.
European Journal of Cancer (Oxford, England : 1990)|August 2, 2011
An international expanded-access programme of everolimus: addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapyViktor Grünwald, Pierre I Karakiewicz, Sevil E Bavbek, et al.
Translational Behavioral Medicine|June 29, 2011
Optimizing eHealth breast cancer interventions: which types of eHealth services are effective?Timothy B Baker, Robert Hawkins, Suzanne Pingree, et al.
European Urology|July 14, 2020
Atezolizumab plus Bevacizumab Versus Sunitinib for Patients with Untreated Metastatic Renal Cell Carcinoma and Sarcomatoid Features: A Prespecified Subgroup Analysis of the IMmotion151 Clinical TrialBrian I Rini, Robert J Motzer, Thomas Powles, et al.
Annals of Surgery|May 15, 2019
Adenosine 2A Receptor Activation Attenuates Ischemia Reperfusion Injury During Extracorporeal Cardiopulmonary ResuscitationJames H Mehaffey, Dustin Money, Eric J Charles, et al.
European Urology Focus|February 11, 2019
Radiological Response Heterogeneity Is of Prognostic Significance in Metastatic Renal Cell Carcinoma Treated with Vascular Endothelial Growth Factor-targeted TherapyPeter E Hall, Scott T C Shepherd, Janet Brown, et al.
Pageof 11